Anurag Agarwal

Anurag Agarwal is a Partner at Osage University Partners (OUP), a venture capital fund that invests exclusively in startups commercializing university research.3 Here are key details about his background and role:

Career at OUP

Anurag joined OUP in 2017 as an Associate focusing on life science investments.13 He was promoted to Principal in February 2017 and became a Partner in January 2023.3 At OUP, he has been involved with investments in several portfolio companies, including Dracen Pharmaceuticals, Cyteir Therapeutics, Homology Medicines, and others.1

Professional Experience

Prior to OUP, Anurag worked as:

• A consultant at Boston Consulting Group (2014-2017), advising healthcare and private equity companies on strategy, business development, and M&A projects.13
• Founder and Director of SCIMALS (2012-2014), a non-profit providing due diligence services to investors in the healthcare/life sciences industry.3
• Consultant at The BALSA Group (2011-2012), working on market opportunity identification for various companies.3

Education

Anurag holds:

• A PhD in Molecular Cell Biology from Washington University School of Medicine (2007-2014).13
• A B.Tech in Biotechnology from the Indian Institute of Technology, Madras (2003-2007).13

Investment Focus

At OUP, Anurag specializes in life science investments.12 His investment range is typically between $5.0M to $10.0M, with a sweet spot of $7.5M.2 He currently serves as a board observer for Dracen Pharmaceuticals.1

Anurag's expertise in life sciences, combined with his consulting background and entrepreneurial experience, positions him well in his role at OUP, where he contributes to identifying and supporting promising university-based startups in the biotech and healthcare sectors.